Antisense modulation of glycogen synthase kinase 3 alpha expression

Details for Australian Patent Application No. 2001232814 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Monia, Brett P; Wyatt, Jacqueline R; Butler, Madeline M.; McKay, Robert

Agent FB Rice

Pub. Number AU-B-2001232814

PCT Pub. Number WO01/52865

Priority 09488856 21.01.00 US

Filing date 16 January 2001

Wipo publication date 31 July 2001

Acceptance publication date 28 October 2004

International Classifications

A61K 031/7115 - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

C12N 005/06 Undifferentiated human, animal or plant cells, e.g. cell lines -

C07H 021/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 031/7125 - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61K 031/712 - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

Event Publications

28 October 2004 Application Accepted

  Published as AU-B-2001232814

24 February 2005 Standard Patent Sealed

6 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001232815

2001232813